Skip to main content
. 2020 Dec 10;6(7):1867–1877. doi: 10.1016/j.bioactmat.2020.12.002

Fig. 5.

Fig. 5

Echocardiographic results showing the improved cardiac function after FGF10 coacervate treatment. (A) The EDA and (B) ESA results of mice 5 days, 2 weeks and 6 week after the treatment of saline, free FGF10 and FGF10 coacervate. (C) FGF10 coacervate treatment significantly increased FAC when compared with saline or free FGF10 groups 6 weeks after MI injury. The EF (D) and FS (E) results of mice 5 days, 2 weeks and 6 weeks after the treatment of saline, free FGF10, heparin+FGF10 and FGF10 coacervate. (F) Representative echocardiography images in M-mode and B-mode of different groups 6 weeks after MI injury. *P < 0.05, **P < 0.01 compared with saline, free FGF10 or heparin+FGF10. All quantitative bars are represented as mean ± S.E.M.